199 related articles for article (PubMed ID: 2266549)
1. Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings.
Clarke DJ; Kelley S; Thinn K; Corbett JA
J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():385-95. PubMed ID: 2266549
[TBL] [Abstract][Full Text] [Related]
2. Psychotropic drugs and mental retardation: 2. A comparison of psychoactive drug use before and after discharge from hospital to community.
Thinn K; Clarke DJ; Corbett JA
J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():397-407. PubMed ID: 1979993
[TBL] [Abstract][Full Text] [Related]
3. The administration of psychotropic and anticonvulsant drugs to children with profound intellectual disability and multiple impairments.
Hogg J
J Intellect Disabil Res; 1992 Dec; 36 ( Pt 6)():473-88. PubMed ID: 1477486
[TBL] [Abstract][Full Text] [Related]
4. A national study of prescribed drugs in institutions and community residential facilities for mentally retarded people.
Hill BK; Balow EA; Bruininks RH
Psychopharmacol Bull; 1985; 21(2):279-84. PubMed ID: 4001292
[TBL] [Abstract][Full Text] [Related]
5. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
Meins W; Auwetter J; Krausz M; Turnier Y
Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
[TBL] [Abstract][Full Text] [Related]
6. Comparative survey of drug use in a community service system.
Zaharia ES; Struxness L
Ment Retard; 1991 Aug; 29(4):191-4. PubMed ID: 1921727
[TBL] [Abstract][Full Text] [Related]
7. Comparison of community and institutional prescription of antiepileptic drugs for individuals with learning disabilities.
Branford D; Collacott RA
J Intellect Disabil Res; 1994 Dec; 38 ( Pt 6)():561-6. PubMed ID: 7881227
[TBL] [Abstract][Full Text] [Related]
8. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
[TBL] [Abstract][Full Text] [Related]
9. Psychopharmacoepidemiology of mental retardation: 1966 to 1995.
Singh NN; Ellis CR; Wechsler H
J Child Adolesc Psychopharmacol; 1997; 7(4):255-66. PubMed ID: 9542696
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland.
O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
J Intellect Disabil Res; 2017 Oct; 61(10):969-983. PubMed ID: 28639298
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of psychoactive drug use among North Dakota group home residents.
Burd L; Fisher W; Vesely BN; Williams M; Kerbeshian J; Leech C
Am J Ment Retard; 1991 Sep; 96(2):119-26. PubMed ID: 1930945
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and patterns of psychotropic and anticonvulsant medication use in children and adolescents referred to residential treatment.
Connor DF; Ozbayrak KR; Harrison RJ; Melloni RH
J Child Adolesc Psychopharmacol; 1998; 8(1):27-38. PubMed ID: 9639077
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
Deb S; Unwin G; Deb T
J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
[TBL] [Abstract][Full Text] [Related]
14. Psychotropic drug use in older developmentally disabled with behavioral difficulties.
Harper DC; Wadsworth JS; Michael AL
Res Dev Disabil; 1989; 10(1):53-60. PubMed ID: 2928579
[TBL] [Abstract][Full Text] [Related]
15. [Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities].
Schützwohl M; Voss E; Stiawa M; Salize HJ; Puschner B; Koch A
Nervenarzt; 2017 Nov; 88(11):1273-1280. PubMed ID: 27638741
[TBL] [Abstract][Full Text] [Related]
16. A study of the prescribing for people with learning disabilities living in the community and in National Health Service care.
Branford D
J Intellect Disabil Res; 1994 Dec; 38 ( Pt 6)():577-86. PubMed ID: 7881229
[TBL] [Abstract][Full Text] [Related]
17. Psychotropic and anticonvulsant drug use by mentally retarded adults across community residential and vocational placements.
Martin JE; Agran M
Appl Res Ment Retard; 1985; 6(1):33-49. PubMed ID: 2859836
[TBL] [Abstract][Full Text] [Related]
18. Psychotropic drug use in intellectually disabled group-home residents with behavioural problems.
Stolker JJ; Koedoot PJ; Heerdink ER; Leufkens HG; Nolen WA
Pharmacopsychiatry; 2002 Jan; 35(1):19-23. PubMed ID: 11819154
[TBL] [Abstract][Full Text] [Related]
19. Regulatory environment and psychotropic use in board-and-care facilities: results of a 10-state study.
Spore D; Mor V; Larrat EP; Hiris J; Hawes C
J Gerontol A Biol Sci Med Sci; 1996 May; 51(3):M131-41. PubMed ID: 8630706
[TBL] [Abstract][Full Text] [Related]
20. [Drug use by mentally handicapped persons in institutions and family-replacing residential facilities].
van Schrojenstein Lantman-de Valk HM; Kessels AG; Haveman MJ; Maaskant MA; Urlings HF; van den Akker M
Ned Tijdschr Geneeskd; 1995 May; 139(21):1083-8. PubMed ID: 7783802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
